SPECLUMA
Live / Applied — First extension granted (statement of use) (as of 28 Oct 2025)
What this means for you
Not registered yet, but its 23 Apr 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98513728
- Mark type
- Stylized text
- Filed
- 23 Apr 2024
- Published for opposition
- 11 Mar 2025
Goods and services
- Class 005 — Pharmaceuticals: Injectable dermal fillers for soft tissue augmentation.
Owner
- Dr. Benjamin Talei, West Hollywood, CA, US
- Dr. Benjamin Talei, West Hollywood, CA, US
Prosecution history
- 29 Oct 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 28 Oct 2025 — SOU EXTENSION 1 GRANTED
- 28 Oct 2025 — SOU EXTENSION 1 FILED
- 28 Oct 2025 — SOU TEAS EXTENSION RECEIVED
- 06 May 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 11 Mar 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 11 Mar 2025 — PUBLISHED FOR OPPOSITION
- 05 Mar 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 20 Feb 2025 — ASSIGNED TO LIE
- 18 Feb 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 14 Feb 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 14 Feb 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 14 Feb 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 14 Nov 2024 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 14 Nov 2024 — NON-FINAL ACTION E-MAILED